Trial intelligence / Profile preview

Acute Effect of Lithium on Responses to Light in Healthy Individuals

NCT07750925Not yet recruiting

Sponsor
Northumbria University
Start
Aug 2026
Primary completion
Apr 2028
Countries
1
01

Overview

Open-label, single-arm trial of lithium carbonate in bipolar disorder (BD), sponsored by Northumbria University. Primary endpoints: Plasma melatonin change in response to light stimulation and Brain lithium signal intensity measured by 7Li-MRI at Day 21. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

lithium carbonate
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT07750925.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07750925.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call